Literature DB >> 21671945

Corticosteroid cross-reactivity: clinical and molecular modelling tools.

M Baeck1, J A Chemelle, A Goossens, J F Nicolas, R Terreux.   

Abstract

BACKGROUND: Corticosteroids have been classified into following four cross-reacting groups in function of their contact-allergenic properties: A, B, C and D, the last subdivided into D1 and D2. Recent data indicate that C(16)-methylated and nonmethylated molecules need to be distinguished, the latter selectively binding with arginine to form stable cyclic adducts and producing considerably more positive reactions than the former. This study compares molecular modelling and patch-test results to determine cross-reactivity patterns.
METHODS: The patch-test results obtained with 66 corticosteroid molecules in 315 previously sensitized subjects were analysed and correlated with modelling and clustering in function of the electrostatic and steric fields of these molecules.
RESULTS: The classification obtained after in silico hydrolysis of C(21) and C(17) esters was selected with an optimal cut into three clusters: the patients who reacted positively to cluster 2 (halogenated molecules from group B, with C(16)/C(17) cis ketal or diol structure) and cluster 3 (halogenated molecules from groups C and D1, C(16)-methylated) also reacted to cluster 1 (molecules mostly from groups A and D2, without C(16)-methyl substitution or halogenation and budesonide). The reverse, however, was not the case.
CONCLUSION: Two patient profiles with probably different areas of immune recognition are identified as follows: the profile 1 patients were allergic to the frequently positively reacting cluster 1 only, for whom electrostatic fields (molecular charge) seem important; the profile 2 patients reacted to clusters 1 and 2 and/or 3, for whom steric fields (structure) are determinant and who probably presented a global recognition of the corticosteroid skeleton. A modified classification is thus proposed.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671945     DOI: 10.1111/j.1398-9995.2011.02666.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  6 in total

Review 1.  Eczematous Drug Eruptions.

Authors:  Amy E Blum; Susan Burgin
Journal:  Am J Clin Dermatol       Date:  2021-02-15       Impact factor: 7.403

2.  Reevaluating Corticosteroid Classification Models in Patient Patch Testing.

Authors:  Joyce Y Chen; James A Yiannias; Matthew R Hall; Molly J Youssef; Lisa A Drage; Mark D P Davis; Yul W Yang
Journal:  JAMA Dermatol       Date:  2022-09-28       Impact factor: 11.816

3.  Anaphylaxis following intralesional triamcinolone acetonide (Kenacort) injection.

Authors:  Wannada Laisuan; Chamard Wongsa; Nizchapha Dchapaphapeaktak; Malinee Tongdee; Jidapa Chatmapanrangsee; Ticha Rerkpattanapipat
Journal:  Asia Pac Allergy       Date:  2017-04-06

4.  Seven Common Allergen Groups Causing Eyelid Dermatitis: Education and Avoidance Strategies.

Authors:  Crystal X Huang; James A Yiannias; Jill M Killian; Joanne F Shen
Journal:  Clin Ophthalmol       Date:  2021-04-12

5.  Allergic contact dermatitis to corticosteroids: experience of a referral clinic from 2014 to 2018.

Authors:  Mariana de Figueiredo Silva Hafner; Amanda Ivanchuk Lopes; Nathalie Mie Suzuki; Rosana Lazzarini
Journal:  An Bras Dermatol       Date:  2022-03-17       Impact factor: 2.113

6.  Prevalence of contact allergy to corticosteroids in a Danish patient population.

Authors:  Sebastian Vigand Svendsen; Rasmus Overgaard Bach; Charlotte G Mortz
Journal:  Contact Dermatitis       Date:  2022-05-26       Impact factor: 6.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.